NURECANSENureca LimitedMinimalNeutral
Announced Wed, 7 May · 17:16 IST

Nureca Limited has informed the Exchange about Copy of Newspaper Publication

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Nureca Limited has submitted copies of newspaper advertisements of its audited financial results for the quarter and year ended March 31, 2025, as required under SEBI Listing Regulations. The results were published in Business Standard (English, all editions) and Nav Shakti (Marathi, Mumbai edition) on May 7, 2025. Key numbers from the results: Q4 FY25 revenue from operations rose to ₹317.50 crore (vs ₹195.63 crore in Q4 FY24), and the company swung to a profit of ₹20.72 crore in Q4 from a loss of ₹44.14 crore a year ago. For the full year FY25, revenue grew to ₹1,146.40 crore from ₹945.21 crore, while the net loss narrowed sharply to ₹6.68 crore from ₹24.42 crore in FY24. EPS for FY25 stood at ₹(0.67), improving from ₹(2.44) in the previous year.

Likely market impact

This is a routine regulatory filing confirming that Nureca has reported a strong rebound in Q4 FY25 with a return to profitability and about 62% growth in quarterly revenue. The full-year loss narrowed significantly, which is a positive sign for shareholders, though the company has not yet returned to an annual profit.